JP2024513048A5 - - Google Patents
Info
- Publication number
- JP2024513048A5 JP2024513048A5 JP2023560598A JP2023560598A JP2024513048A5 JP 2024513048 A5 JP2024513048 A5 JP 2024513048A5 JP 2023560598 A JP2023560598 A JP 2023560598A JP 2023560598 A JP2023560598 A JP 2023560598A JP 2024513048 A5 JP2024513048 A5 JP 2024513048A5
- Authority
- JP
- Japan
- Prior art keywords
- lnp
- lipids
- approximately
- molar percentage
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169118P | 2021-03-31 | 2021-03-31 | |
| US63/169,118 | 2021-03-31 | ||
| PCT/US2022/022642 WO2022212576A1 (en) | 2021-03-31 | 2022-03-30 | Compositions and methods for delivery of rna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513048A JP2024513048A (ja) | 2024-03-21 |
| JP2024513048A5 true JP2024513048A5 (cg-RX-API-DMAC10.html) | 2025-04-01 |
Family
ID=83456716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560598A Pending JP2024513048A (ja) | 2021-03-31 | 2022-03-30 | Rnaの送達のための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220347112A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4312942A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024513048A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117396193A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022246851A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3215112A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL307319A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022212576A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117771213A (zh) * | 2023-01-10 | 2024-03-29 | 北京剂泰医药科技有限公司 | 脂质纳米颗粒组合物及其用途 |
| TW202509222A (zh) * | 2023-05-08 | 2025-03-01 | 美商默沙東有限責任公司 | 編碼諾羅病毒vp1抗原之多核苷酸及其用途 |
| WO2025049632A1 (en) * | 2023-08-29 | 2025-03-06 | Rejuvenation Technologies Inc. | Compositions and methods for broad delivery of rna to tissue |
| WO2025255027A1 (en) * | 2024-06-03 | 2025-12-11 | Flagship Labs 114, Inc. | Lipid nanoparticles for topical delivery |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026010842A1 (en) * | 2024-07-01 | 2026-01-08 | The Trustees Of The University Of Pennsylvania | Use of lipid nanoparticle mrna for tert specific cancer immunotherapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10525075B2 (en) * | 2013-02-22 | 2020-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds, compositions, methods, and kits relating to telomere extension |
| IL270631B2 (en) * | 2017-05-16 | 2024-03-01 | Translate Bio Inc | Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr |
| CA3094057C (en) * | 2018-03-27 | 2025-04-08 | Nof Corporation | CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS |
| GB2600800B (en) * | 2018-09-04 | 2023-08-16 | Univ Texas | Compositions and methods for organ specific delivery of nucleic acids |
| CA3124524A1 (en) * | 2019-01-04 | 2020-07-09 | Oncorus, Inc. | Encapsulated rna polynucleotides and methods of use |
-
2022
- 2022-03-30 US US17/709,108 patent/US20220347112A1/en active Pending
- 2022-03-30 CN CN202280026001.6A patent/CN117396193A/zh active Pending
- 2022-03-30 CA CA3215112A patent/CA3215112A1/en active Pending
- 2022-03-30 EP EP22782138.6A patent/EP4312942A4/en active Pending
- 2022-03-30 WO PCT/US2022/022642 patent/WO2022212576A1/en not_active Ceased
- 2022-03-30 AU AU2022246851A patent/AU2022246851A1/en active Pending
- 2022-03-30 IL IL307319A patent/IL307319A/en unknown
- 2022-03-30 JP JP2023560598A patent/JP2024513048A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL307319A (en) | Compositions and methods for delivery of rna | |
| US20260125339A1 (en) | Ionizable cationic lipids | |
| JP2025084968A5 (cg-RX-API-DMAC10.html) | ||
| US12102720B2 (en) | Cleavable lipids | |
| US11547764B2 (en) | Lipid nanoparticle compositions and methods for MRNA delivery | |
| JP7586886B2 (ja) | 改善されたmRNA装填脂質ナノ粒子、およびそれを作製するプロセス | |
| US20220072152A1 (en) | Composition and Methods for Treatment of Ornithine Transcarbamylase Deficiency | |
| US10576166B2 (en) | Liver specific delivery of messenger RNA | |
| ES2971849T3 (es) | Compuestos lipídicos catiónicos y composiciones de los mismos para su uso en la administración de ARN mensajero | |
| JP2022532213A5 (cg-RX-API-DMAC10.html) | ||
| JP7744354B2 (ja) | Mrna担持脂質ナノ粒子を調製する改善された方法 | |
| JP2024519715A5 (cg-RX-API-DMAC10.html) | ||
| US12564645B2 (en) | Methods for treatment of methylmalonic acidemia | |
| US20210187122A1 (en) | Messenger rna therapy for the treatment of friedreich's ataxia | |
| US20220133631A1 (en) | Process of preparing ice-based lipid nanoparticles | |
| AU2021232818A1 (en) | Mrna therapy for pompe disease | |
| US20220287966A1 (en) | Stable Liquid Lipid Nanoparticle Formulations |